Leaflet PARNIDO 9mg prolonged-release tablets

Indicated for: schizophrenia; bipolar disorder

Route of administration: oral

Substance: paliperidone (antipsychotic)

ATC: N05AX13 (Nervous system | Antipsychotics | Other antipsychotics)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Seizure risk
Seizure risk

This medicine may increase the risk of seizures.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Paliperidone is an antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It belongs to the class of atypical antipsychotics and works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.

The medication is administered orally or as long-acting injectable formulations, as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.

Side effects may include drowsiness, dizziness, weight gain, gastrointestinal disturbances, or, in rare cases, neuroleptic malignant syndrome.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of paliperidone.

General data about PARNIDO 9mg

  • Substance: paliperidone
  • Date of latest medicines list: 01-06-2026
  • Product code: W65239002
  • Concentration: 9mg
  • Pharmaceutical form: prolonged-release tablets
  • Quantity: 30
  • Product type: Generic medicine
  • Price: 250.23 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: KRKA ,D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA ,D.D., NOVO MESTO - SLOVENIA
  • Number: 10804/2018/02
  • Shelf life: 2 years

Concentrations available for paliperidone

  • 1000mg
  • 100mg
  • 12mg
  • 150mg
  • 175mg
  • 25mg
  • 263mg
  • 350mg
  • 3mg
  • 50mg
  • 525mg
  • 6mg
  • 700mg
  • 75mg
  • 9mg

Compensation lists for PARNIDO 9mg KRKA

G15 (C1) - Mental disorders

Price

Copayment

Patient

250.23 RON

250.23 RON

0.00 RON